CTLA-4 polymorphisms in allergy and asthma and the TH1/ T H2 paradigm

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 2, 2004, Pages 280-287

  Munthe Kaas, Monica Cheng ^a   Håkon Carlsen, Kai ^b   Helms, Peter J ^b   Gerritsen, Jorrit ^b   Whyte, Moira ^b   Feijen, Marlies ^b   Skinningsrud, Beate ^b   Main, Margaret ^b   Ng Man Kwong, Georges ^b   Lie, Benedicte A ^b   Lødrup Carlsen, Karin C ^a   Undlien, Dag E ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Ullevå University Hospital ^*

Author keywords

allergy; association study; Asthma; atopy; BHR; bronchial hyperresponsiveness; Bronchial hyperresponsiveness; CTLA 4; CTLA 4 polymorphisms; Cytotoxic T lymphocyte antigen 4; FEV1; flCTLA 4; genetic analysis; Ige

Indexed keywords

ALLERGEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN E; METHACHOLINE;

ADOLESCENT; ADULT; ALLERGY; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EUROPE; FAMILY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MALE; PREDICTION; PRICK TEST; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIZATION; SINGLE NUCLEOTIDE POLYMORPHISM; TH1 CELL; TH2 CELL;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; ASTHMA; CHILD; FEMALE; HAPLOTYPES; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TH1 CELLS; TH2 CELLS;

EID: 4344560400     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.03.050     Document Type: Article

References (35)

1. Johansson S.G., Hourihane J.O., Bousquet J., Bruijnzeel-Koomen C., Dreborg S., Haahtela T., et al. A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy. 56:2001;813-824
2. Van Eerdewegh P., Little R.D., Dupuis J., Del Mastro R.G., Falls K., Simon J., et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature. 418:2002;426-430
3. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet. 15:1997;389-392
4. Koppelman G.H., Stine O.C., Xu J., Howard T.D., Zheng S.L., Kauffman H.F., et al. Genome-wide search for atopy susceptibility genes in Dutch families with asthma. J Allergy Clin Immunol. 109:2002;498-506
5. Lee S.Y., Lee Y.H., Shin C., Shim J.J., Kang K.H., Yoo S.H., et al. Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest. 122:2002;171-176
6. Howard T.D., Postma D.S., Koppelman G.A., Koppelman G.H., Zheng S.L., Wysong A.K., et al. Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J Allergy Clin Immunol. 110:2002;743-751
7. Hizawa N., Yamaguchi E., Jinushi E., Konno S., Kawakami Y., Nishimura M. Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B. J Allergy Clin Immunol. 108:2001;74-79
8. Yang K.D., Liu C.A., Chang J.C., Chuang H., Ou C.Y., Hsu T.Y., et al. Polymorphism of the immune-braking gene CTLA-4 (+49) involved in gender discrepancy of serum total IgE levels and allergic diseases. Clin Exp Allergy. 34:2004;32-37
9. Heinzmann A., Plesnar C., Kuehr J., Forster J., Deichmann K.A. Common polymorphisms in the CTLA-4 and CD28 genes at 2q33 are not associated with asthma or atopy. Eur J Immunogenet. 27:2000;57-61
10. Salomon B., Bluestone J.A. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol. 19:2001;225-252
11. Walunas T.L., Bluestone J.A. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J Immunol. 160:1998;3855-3860
12. Kato T., Nariuchi H. Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation. J Immunol. 164:2000;3554-3562
13. Bour-Jordan H., Grogan J.L., Tang Q., Auger J.A., Locksley R.M., Bluestone J.A. CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment. Nat Immunol. 4:2003;182-188
14. Grohmann U., Puccetti P. CTLA-4, T helper lymphocytes and dendritic cells: an internal perspective of T-cell homeostasis. Trends Mol Med. 9:2003;133-135
15. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science. 270:1995;985-988
16. Kristiansen O.P., Larsen Z.M., Pociot F. CTLA-4 in autoimmune diseases - a general susceptibility gene to autoimmunity? Genes Immun. 1:2000;170-184
17. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423:2003;506-511
18. Cardwell C.R., Shields M.D., Carson D.J., Patterson C.C. A meta-analysis of the association between childhood type 1 diabetes and atopic disease. Diabetes Care. 26:2003;2568-2574
19. Phagoo S.B., Wilson N.M., Silverman M. Skin prick testing using allergen-coated lancets: a comparison between a multiple lancet device and a single lancet applied with varying pressures. Clin Exp Allergy. 21:1991;589-593
20. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 144:1991;1202-1218
21. Crapo R.O., Morris A.H., Gardner R.M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis. 123:1981;659-664
22. Wang X., Dockery D.W., Wypij D., Gold D.R., Speizer F.E., Ware J.H., et al. Pulmonary function growth velocity in children 6 to 18 years of age. Am Rev Respir Dis. 148:1993;1502-1508
23. Hargreave F.E., Ryan G., Thomson N.C., O'Byrne P.M., Latimer K., Juniper E.F., et al. Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance. J Allergy Clin Immunol. 68:1981;347-355
24. O'Connell J.R., Weeks D.E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 63:1998;259-266
25. Ewens W.J., Spielman R.S. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet. 57:1995;455-464
26. Martin E.R., Monks S.A., Warren L.L., Kaplan N.L. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am J Hum Genet. 67:2000;146-154
27. Mattila P.S., Tarkkanen J., Saxen H., Pitkaniemi J., Karvonen M., Tuomilehto J. Predisposition to atopic symptoms to inhaled antigens may protect from childhood type 1 diabetes. Diabetes Care. 25:2002;865-868
28. Decreased prevalence of atopic diseases in children with diabetes. The EURODIAB Substudy 2 Study Group. J Pediatr. 137:2000;470-474
29. Stene L.C., Nafstad P. Relation between occurrence of type 1 diabetes and asthma. Lancet. 357:2001;607-608
30. O'Shea J.J., Paul W.E. Regulation of T(H)1 differentiation - controlling the controllers. Nat Immunol. 3:2002;506-508
31. Jaffar Z., Roberts K., Pandit A., Linsley P., Djukanovic R., Holgate S. B7 costimulation is required for IL-5 and IL-13 secretion by bronchial biopsy tissue of atopic asthmatic subjects in response to allergen stimulation. Am J Respir Cell Mol Biol. 20:1999;153-162
32. Oaks M.K., Hallett K.M., Penwell R.T., Stauber E.C., Warren S.J., Tector A.J. A native soluble form of CTLA-4. Cell Immunol. 201:2000;144-153
33. Deurloo D.T., van Esch B.C., Hofstra C.L., Nijkamp F.P., van Oosterhout A.J. CTLA4-IgG reverses asthma manifestations in a mild but not in a more "severe" ongoing murine model. Am J Respir Cell Mol Biol. 25:2001;751-760
34. Kremer J.M., Westhovens R., Leon M., Di Giorgio E., Alten R., Steinfeld S., et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med. 349:2003;1907-1915
35. Sengler C., Haider A., Sommerfeld C., Lau S., Baldini M., Martinez F., et al. Evaluation of the CD14 C-159 T polymorphism in the German Multicenter Allergy Study cohort. Clin Exp Allergy. 33:2003;166-169